APRECIA
Live / Allowed — Fourth extension granted (statement of use) (as of 19 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Nov 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98289671
- Mark type
- Stylized text
- Filed
- 29 Nov 2023
- Published for opposition
- 25 Jun 2024
- Attorney of record
- Brian O'Donnell
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, compounds in a unitary solid dosage form made by a three-dimensional printing process for the rapid dispersion of a wide variety of therapeutic agents
- Class 040 — Treatment of materials: Pharmaceutical manufacturing to the order and/or specification of others
- Class 042 — Scientific and technological services: Development of pharmaceutical and nutraceutical preparations for others; research and development in the pharmaceutical and nutraceutical fields for others
Owner
- Aprecia Pharmaceuticals, LLC, Mason, OH, US
- Aprecia Pharmaceuticals, LLC, Blue Ash, OH, US
Prosecution history
- 20 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Aug 2026 — SOU EXTENSION 4 GRANTED
- 19 Aug 2026 — SOU EXTENSION 4 FILED
- 19 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Feb 2026 — SOU EXTENSION 3 GRANTED
- 18 Feb 2026 — SOU EXTENSION 3 FILED
- 18 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 14 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Aug 2025 — SOU EXTENSION 2 GRANTED
- 13 Aug 2025 — SOU EXTENSION 2 FILED
- 13 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Mar 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 12 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED